Rezolute (RZLT) Other financing activities (2012 - 2025)
Rezolute's (RZLT) quarterly Other financing activities came in at $35000.0 in Q3 2025, down 93.92% year-on-year from $576000.0 in Q3 2024, and down 92.47% quarter-over-quarter from $465000.0 in Q2 2025.
Rezolute (RZLT) Other financing activities (2012 - 2025) Analysis & Trends
Rezolute has disclosed Other financing activities across 10 years of filings, most recently posting $35000.0 for Q3 2025.
- Other financing activities for Q3 2025 came in at $35000.0, down 93.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $500000.0 (down 18.83% YoY), and the FY2025 annual result was $1.1 million, up 236.19% from the prior year.
- Other financing activities came in at $35000.0 for Q3 2025 at Rezolute, down from $465000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $662000.0 in Q2 2021 to a low of -$3.5 million in Q1 2021.
- The 4-year median for Other financing activities is $104000.0 (2021), against an average of -$159333.3.
- Across the five-year window, Other financing activities plunged 131.07% in 2021 and surged 2013.64% in 2025, its largest moves.
- Rezolute's Other financing activities stood at $104000.0 in 2021, then jumped by 44.23% to $150000.0 in 2022, then tumbled by 88.0% to $18000.0 in 2024, then jumped by 94.44% to $35000.0 in 2025.
- The last three Other financing activities figures came in at $35000.0 (Q3 2025), $465000.0 (Q2 2025), and $18000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 465,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Sep 30, 2021 | 104,000.00 |
| Sep 30, 2021 | 104,000.00 |
| Jun 30, 2021 | 662,000.00 |
| Jun 30, 2021 | 662,000.00 |
| Mar 31, 2021 | -3.47 Mn |
| Mar 31, 2021 | -3.47 Mn |
| Dec 31, 2020 | 3.54 Mn |
| Dec 31, 2020 | 3.54 Mn |